COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

December 23, 2020

Primary Completion Date

May 23, 2021

Study Completion Date

June 23, 2021

Conditions
SARS-COV2 InfectionCOVID-19 DiseaseHospitalized Patients
Interventions
DRUG

low molecular weight Heparin as standard of care treatment

STANDARD OF CARE

Trial Locations (1)

45500

University General Hospital of Ioannina, Ioannina

All Listed Sponsors
collaborator

INTERNAL MEDICINE DEPARTMENT, 1ST WARD

UNKNOWN

lead

University Hospital, Ioannina

OTHER

NCT04787510 - COVID-19 Disease and Coagulopathy: Assessment of Clotting Factor Levels in Patients With SARS-CoV-2 Infection | Biotech Hunter | Biotech Hunter